Evidence map›Paper›PMID 35910058›Full record

ArticleThe Pan African medical journal2022

[Relapsed Hodgkin lymphoma with only breast involvement: a rare case report].

Najat Lasri, Fatimazahra Lahlimi, Mohammed Ilias Tazi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Najat LasriService d´Hématologie Clinique et de Greffe de Moelle, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Maroc.
Fatimazahra LahlimiService d´Hématologie Clinique et de Greffe de Moelle, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Maroc.
Mohammed Ilias TaziService d´Hématologie Clinique et de Greffe de Moelle, Centre Hospitalier Universitaire Mohammed VI, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Maroc.
Cadi Ayyad University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsed Hodgkin lymphoma with only breast involvement is rare. There is no specific clinical presentation. It can mimic another breast cancer or inflammatory disease. The histological profile is often misleading in the pauci-cellular forms where the inflammatory component predominates. We report a case of an 18-year-old female patient treated for mixed-cell Hodgkin lymphoma who was admitted 6 months after complete remission for a left breast inflammatory nodule. The first assessment showed breast abscess. As there was not a good outcome despite adapted antibiotic, more investigations were added and showed a relapsed Hodgkin lymphoma with only breast involvement. The patient is currently receiving a 4

Indexed as

Hodgkin DiseaseAdolescentAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansNeoplasm Recurrence, LocalRemission InductionSalvage TherapyTreatment OutcomeBreast cancercase reportHodgkin’s lymphomasalvage therapy

Identifiers

PMID35910058
PMCPMC9288118
OpenAlexW4285256576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.